UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000014700
Receipt number R000017086
Scientific Title The effectiveness of self-care program for breast-cancer-treatment-related lymphedema;randomized pilot study
Date of disclosure of the study information 2014/07/29
Last modified on 2016/01/29 09:03:14

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effectiveness of self-care program for breast-cancer-treatment-related lymphedema;randomized pilot study

Acronym

The effectiveness of self-care program for breast-cancer-treatment-related lymphedema;randomized pilot study

Scientific Title

The effectiveness of self-care program for breast-cancer-treatment-related lymphedema;randomized pilot study

Scientific Title:Acronym

The effectiveness of self-care program for breast-cancer-treatment-related lymphedema;randomized pilot study

Region

Japan


Condition

Condition

breast-cancer-treatment-related lymphedema

Classification by specialty

Surgery in general Breast surgery Dermatology
Rehabilitation medicine Nursing

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The purposes of this randomized, controlled pilot study is to assess the effects of the 6 months' self-care program for breast-cancer-treatment-related lymphedema for next randomized controlled study.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Phase II


Assessment

Primary outcomes

Extracellular fluid/ Intracellular fluid ratio

Key secondary outcomes

upper limb volume
edema volume
Tissue Tonometry
Transepidermal Water Loss
lymphedema related symptoms
lymphedema self care
Health related QOL


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Behavior,custom Maneuver

Interventions/Control_1

6 month BCRL self-care program including 1)Super slow radio exercise, 2)Arm exercise using Tai-Chi breathing technique, 3)Self-lymphatic drainage with skin moisturizing care

Interventions/Control_2

standard self-care

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

1)unilateral breast-cancer-treatment-related lymphedema, CTCAE v4.0 edema:limb Grade >1
2)>6month from active treatment
3)ECOG PS 0-2
4) be able to responding questionnaire and self-care
5)submitted written consent as a participant

Key exclusion criteria

1)Any sign of skin damage or sign of acute inflammation on affected arm
2)cancer recurrence
3)pregnant or attempting conception
4)Insertion of cardiac pacemaker and ICD

Target sample size

40


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yoko Arinaga

Organization

Tohoku University

Division name

Community Cancer Center Program Graduate School of Medicine

Zip code


Address

4-1 Seiryou-machi, Aoba-ku, Sendai-city

TEL

022-717-7087

Email

arinaga@med.tohoku.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yoko Arinaga

Organization

Tohoku University

Division name

Community Cancer Center Program Graduate School of Medicine

Zip code


Address

4-1 Seiryou-machi, Aoba-ku, Sendai-city

TEL

022-717-7087

Homepage URL


Email

arinaga@med.tohoku.ac.jp


Sponsor or person

Institute

Tohoku University

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology (MEXT)

Organization

Division

Category of Funding Organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

YES

Study ID_1

25463419

Org. issuing International ID_1

Ministry of Education, Culture, Sports, Science and Technology (MEXT)

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

宮城県:東北大学医学系研究科地域がん医療推進センター、東北大学大学院医学系研究科保健学専攻がん看護学分野、東北大学大学院医科学専攻腫瘍外科学分野、東北大学大学院医学系研究科医科学専攻皮膚科学分野、東北大学病院、東北公済病院、宮城県立がんセンター、一番町きじまクリニック
福島県:福島県立医科大学付属病院、福島県立医科大学器官制御外科学講座、福島県立医科大学衛生学・予防医学講座


Other administrative information

Date of disclosure of the study information

2014 Year 07 Month 29 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2014 Year 07 Month 29 Day

Date of IRB


Anticipated trial start date

2014 Year 09 Month 01 Day

Last follow-up date

2015 Year 10 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2014 Year 07 Month 29 Day

Last modified on

2016 Year 01 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017086